Showing results (1701-1710 of 3,660) with videos related to

Sort By:
Pageof 366
Breast (Edinburgh, Scotland)|October 9, 2023
Prognostic impact of reduced HER2 protein expression in post-neoadjuvant therapy resection specimens: A single institution experience and review of the literatureJan Paredes Mogica, Haiming Tang, Yuanxin Liang, et al.
Breast (Edinburgh, Scotland)|October 19, 2023
Our house believes that: The clipped lymph node is the true sentinel node after neoadjuvant chemotherapy in N+ patientsBenigno Acea-Nebril, Alejandra García-Novoa, Alberto Bouzón Alejandro, et al.
Breast (Edinburgh, Scotland)|October 19, 2023
Breast cancer risk prediction using Tyrer-Cuzick algorithm with an 18-SNPs polygenic risk score in a European population with below-average breast cancer incidenceTjaša Oblak, Petra Škerl, Benjamin J Narang, et al.
Breast (Edinburgh, Scotland)|September 16, 2023
Additional intraoperative subpectoral plane block vs conventional pain control: A comparison of shoulder movement in patients with mastectomySivaporn Pondeenana, Chao Saenghirunvattana, Patcharin Intarakhao, et al.
Breast (Edinburgh, Scotland)|September 25, 2024
Financial toxicity in breast cancer patients receiving regional nodal irradiation: Variation by cancer subtypeGrace L Smith, Benjamin D Smith, Chi-Fang Wu, et al.
Breast (Edinburgh, Scotland)|September 12, 2024
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter?Rebecca Pedersini, Greta Schivardi, Marta Laganà, et al.
Breast (Edinburgh, Scotland)|September 7, 2024
Stereotactic body radiotherapy using CyberKnife versus interstitial brachytherapy in accelerated partial breast irradiation on left-sided breast: A comparison of dosimetric characteristics and preliminary clinical resultsTing-Na Wei, Jia-Fu Lin, Mei-Chun Cheng, et al.
Breast (Edinburgh, Scotland)|February 28, 2026
Safety and effectiveness of post-trastuzumab deruxtecan regimens in patients with HER2-positive metastatic breast cancer who discontinued trastuzumab deruxtecan due to interstitial lung diseaseJunji Tsurutani, Kazuki Nozawa, Toru Mukohara, et al.
Breast (Edinburgh, Scotland)|March 3, 2026
Real-world treatment patterns and outcomes in HER2-low, HR+ metastatic breast cancer patients previously treated with endocrine therapy in the United StatesShanu Modi, Danalyn Byng, Suyuan Zhang, et al.
Breast (Edinburgh, Scotland)|February 20, 2026
Real-world treatment patterns and sequencing in patients with advanced / metastatic HR+/HER2- breast cancer in Europe and the United StatesReshma Mahtani, Beata Korytowsky, Chloe Grace Rose, et al.
Pageof 366